Genotype-Specific Neutralization and Protection by Antibodies against Dengue Virus Type 3

Dengue viruses (DENV) comprise a family of related positive-strand RNA viruses that infect up to 100 million people annually. Currently, there is no approved vaccine or therapy to prevent infection or diminish disease severity. Protection against DENV is associated with the development of neutralizi...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Brien, James D., Austin, S. Kyle, Sukupolvi-Petty, Soila, O'Brien, Katie M., Johnson, Syd, Fremont, Daved H., Diamond, Michael S.
Format: Artigo
Idioma:Inglês
Publicat: American Society for Microbiology (ASM) 2010
Matèries:
Vaccines and Antiviral Agents
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC2950583/
https://ncbi.nlm.nih.gov/pubmed/20702644
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/JVI.01190-10
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars